Don’t miss the latest developments in business and finance.

Alkem Laboratories launches Ibuprofen and Famotidine Tablets in US market

Image
Capital Market
Last Updated : Aug 04 2021 | 9:31 AM IST
Alkem Laboratories (Alkem) today announced the launch of Ibuprofen and Famotidine Tablets (800 mg/26.6 mg) in the United States, following an approval from the United States Food and Drug Administration (US FDA).

Ibuprofen and Famotidine Tablets is AB-rated generic therapeutic equivalent version of Horizon Medicines LLC's Duexis Tablets, 800 mg/26.6 mg. This is the first generic approval of Duexis Tablets, 800 mg/26.6 mg by the US FDA. The launch is a subject of ongoing litigation.

Powered by Capital Market - Live News

Also Read

First Published: Aug 04 2021 | 9:19 AM IST

Next Story